Fiduciary Trust’s Voyager Therapeutics VYGR Stock Holding History

Fiduciary Trust’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Hold	334,397	–	–	0.01%	389
2026 Q1	$1.29M	Hold	334,397	–	–	0.02%	366
2025 Q4	$1.31M	Hold	334,397	–	–	0.01%	358
2025 Q3	$1.56M	Buy	334,397 +75,000	+29%	+$271K	0.02%	326
2025 Q2	$807K	Hold	259,397	–	–	0.01%	449
2025 Q1	$877K	Hold	259,397	–	–	0.01%	414
2024 Q4	$1.47M	Hold	259,397	–	–	0.02%	296
2024 Q3	$1.52M	Hold	259,397	–	–	0.02%	299
2024 Q2	$2.05M	Hold	259,397	–	–	0.03%	245
2024 Q1	$2.41M	Hold	259,397	–	–	0.04%	227
2023 Q4	$2.19M	Hold	259,397	–	–	0.04%	232
2023 Q3	$2.01M	Buy	259,397 +3,837	+2%	+$35K	0.04%	233
2023 Q2	$2.93M	Buy	255,560 +3,257	+1%	+$33.7K	0.05%	204
2023 Q1	$1.95M	Buy	252,303 +3,774	+2%	+$30K	0.04%	231
2022 Q4	$1.52M	Hold	248,529	–	–	0.03%	276
2022 Q3	$1.47M	Hold	248,529	–	–	0.03%	268
2022 Q2	$1.47M	Hold	248,529	–	–	0.03%	274
2022 Q1	$1.89M	Hold	248,529	–	–	0.03%	263
2021 Q4	$674K	Hold	248,529	–	–	0.01%	419
2021 Q3	$654K	Buy	248,529 +93,186	+60%	+$303K	0.01%	417
2021 Q2	$642K	Hold	155,343	–	–	0.01%	419
2021 Q1	$732K	Hold	155,343	–	–	0.01%	389
2020 Q4	$1.11M	Hold	155,343	–	–	0.02%	306
2020 Q3	$1.66M	Hold	155,343	–	–	0.04%	235
2020 Q2	$1.96M	Hold	155,343	–	–	0.05%	214
2020 Q1	$1.42M	Hold	155,343	–	–	0.04%	225
2019 Q4	$2.17M	Hold	155,343	–	–	0.05%	201
2019 Q3	$2.67M	Hold	155,343	–	–	0.07%	179
2019 Q2	$4.23M	Hold	155,343	–	–	0.11%	135
2019 Q1	$2.97M	Hold	155,343	–	–	0.08%	158
2018 Q4	$1.46M	Hold	155,343	–	–	0.04%	205
2018 Q3	$2.94M	Buy	155,343 +772	+0.5%	+$14.8K	0.08%	164
2018 Q2	$3.02M	Buy	154,571 +772	+0.5%	+$15.3K	0.09%	159
2018 Q1	$2.89M	Buy	153,799 +44,765	+41%	+$967K	0.09%	165
2017 Q4	$1.81M	Hold	109,034	–	–	0.05%	202
2017 Q3	$2.25M	Hold	109,034	–	–	0.07%	177
2017 Q2	$977K	Buy	109,034 +473	+0.4%	+$4.76K	0.03%	250
2017 Q1	$1.44M	Buy	108,561 +17,386	+19%	+$211K	0.04%	216
2016 Q4	$1.16M	Hold	91,175	–	–	0.04%	237
2016 Q3	$1.09M	Buy	+91,175	New	+$1.23M	0.04%	238

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fiduciary Trust's VYGR Position: Q2 2026 in Review

Fiduciary Trust held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 334,397 shares worth $1.17M. The position accounts for 0.01% of the portfolio, ranked #389.

Fiduciary Trust first reported a position in VYGR in Q3 2016 and has held it in 40 quarters since. The position peaked at $4.23M in Q2 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

Fiduciary Trust held 334,397 shares of Voyager Therapeutics worth $1.17M as of Q2 2026.
Fiduciary Trust left its Voyager Therapeutics share count unchanged in Q2 2026.
Voyager Therapeutics made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #389 holding.
Fiduciary Trust first reported a position in Voyager Therapeutics in Q3 2016 and has held it in 40 quarters since.
Fiduciary Trust's Voyager Therapeutics position peaked at $4.23M in Q2 2019.
136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.